192 related articles for article (PubMed ID: 16917560)
1. Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial.
Ferreira JB; Rapoport PB; Sakano E; Kós AO; Piltcher OB; Pignatari SS; Pinheiro SD; Mocellin M
Braz J Otorhinolaryngol; 2006; 72(1):104-11. PubMed ID: 16917560
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections.
Pareek A; Kulkarni M; Daga S; Deshpande A; Chandurkar N
Expert Opin Pharmacother; 2008 Nov; 9(16):2751-7. PubMed ID: 18937610
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.
Matthews P; Alpert M; Rahav G; Rill D; Zito E; Gardiner D; Pedersen R; Babinchak T; McGovern PC;
BMC Infect Dis; 2012 Nov; 12():297. PubMed ID: 23145952
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of uncomplicated urinary tract infections. Effectiveness and tolerance of sultamicillin compared with amoxicillin/clavulanic acid].
Schütz W
Fortschr Med; 1990 Jun; 108(18):365-8. PubMed ID: 2198211
[TBL] [Abstract][Full Text] [Related]
5. Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
Lode H
Int J Antimicrob Agents; 2001 Sep; 18(3):199-209. PubMed ID: 11673031
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media.
Chan KH; Bluestone CD; Tan LS; Reisinger KS; Blatter MM; Fall PA
Pediatr Infect Dis J; 1993 Jan; 12(1):24-8. PubMed ID: 8417421
[TBL] [Abstract][Full Text] [Related]
7. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.
Lipsky BA; Itani K; Norden C;
Clin Infect Dis; 2004 Jan; 38(1):17-24. PubMed ID: 14679443
[TBL] [Abstract][Full Text] [Related]
8. Sultamicillin experiences in the field of internal medicine.
Hara K; Kobayashi H
APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
[TBL] [Abstract][Full Text] [Related]
9. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
Dajani A
J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of cefprozil versus amoxicillin/clavulanate for the treatment of adults with severe sinusitis.
Adelglass J; Bundy JM; Woods R
Clin Ther; 1998; 20(6):1115-29. PubMed ID: 9916606
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S; Breton J; Wynne B
Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
[TBL] [Abstract][Full Text] [Related]
12. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.
Alves Galvão MG; Rocha Crispino Santos MA; Alves da Cunha AJ
Cochrane Database Syst Rev; 2014 Feb; (2):CD007880. PubMed ID: 24535959
[TBL] [Abstract][Full Text] [Related]
15. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
[TBL] [Abstract][Full Text] [Related]
17. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Poachanukoon O; Kitcharoensakkul M
Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
[TBL] [Abstract][Full Text] [Related]
19. Rational antibiotic therapy and the position of ampicillin/sulbactam.
Lode HM
Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
[TBL] [Abstract][Full Text] [Related]
20. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
